jens juul holst glp-1 Holst, Md, DMSc | Scholars The Story of GLP-1 -

Unlike semaglutide and tirzepatide, where the FDA has now spent years responding to shortages, compounding, and illicit imports, many of these newer drugs are still investigational

In January 2026, the company announced a strategic initiative to expand its PharmaPatch microneedle patch platform into select therapeutic peptides

L ,

As a result, Nrf2 migrates to the nucleus where it promotes the expression of genes involved in antioxidant defense (208) ( Figure 2B )

After using this tool/service, the authors reviewed and edited the content as needed and took full responsibility for the publications content

And while there was apparent lean body mass loss, scientists found it was relatively modest when compared to the amount of body mass loss